Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GCSF in Dystrophic Epidermolysis Bullosa
NCT01538862Phase 2Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Feb 2012
- Primary completion
- Oct 2014
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of granulocyte colony-stimulating factor in Recessive Dystrophic Epidermolysis Bullosa (RDEB), sponsored by Vanderbilt University Medical Center. Started Feb 2012; status: completed.
02
Drugs
granulocyte colony-stimulating factor
03
Conditions
Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Beyond the preview
Go deeper on NCT01538862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01538862.